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Evaluation of Serological Tests for the Diagnosis of
Visceral Leishmaniasis*
Aim: Visceral leishmaniasis (VL) is a zoonosis that affects both animals and man. VL is seen sporadically in the
Aegean, Mediterranean, Black Sea and central Anatolian regions of Turkey. The aim of this study was to
evaluate serological tests for the diagnosis of VL.
Materials and Methods: The performance of two agglutination tests based on freeze-dried whole
promastigote Leishmania antigen, i.e. Fast Agglutination Screening Test (FAST) and Direct Agglutination Test
(DAT), an Indirect Immunofluorescent Antibody Test (IFAT), and an Enzyme-Linked Immunosorbent Assay
(ELISA) using soluble antigen were compared to parasitological diagnosis in the serum specimens of 59
patients with the clinical suspicion of VL presenting at a tertiary care center in Ankara.
Results: Twenty-four patients had a parasitologically proven VL infection and 35 VL suspects had a negative
parasitological work-up. DAT and IFAT were positive in all parasitologically positive patients whereas FAST and
ELISA were positive in 23 (95.8%) out of 24 of the cases. Out of 35 clinically suspected but parasitologically
negative VL cases, four showed a positive reaction in DAT, five in FAST and IFA and six in ELISA. The
agreement between the tests was excellent (agreement: 90-96.6%; κ value: 0.82-0.93).
Conclusions: The present study shows that the FAST is a rapid and cost-effective screening test. DAT, IFAT
and ELISA tests are all very sensitive tests, but on grounds of simplicity and low cost, the DAT is considered
the most suitable test for the sero-diagnosis of VL in our region.
Key Words: Parasitic diseases, protozoon infections, leishmaniasis, visceral, kala azar, Leishmania donovani,
L. donovani promastigote antigen, serology, visceral leishmaniasis, diagnosis, serology, agglutination, IFA,
ELISA

Visseral Leishmaniasis Tan›s›nda Serolojik Testlerin De¤erlendirilmesi
Amaç: Visseral leishmaniasis (VL) hayvan ve insanlar› etkiliyen bir zoonozdur. VL ülkemizde Ege, Akdeniz,
Karadeniz ve ‹ç Anadolu bölgesinde sporadik olarak görülmektedir. Bu çal›ﬂmada, VL tan›s›nda parazitolojik
tekniklerle birlikte serolojik testlerin de¤erlendirilmesi amaçlanm›ﬂt›r.
Yöntem ve Gereç: Ankara’da üçüncü basamak sa¤l›k hizmeti veren hastanelerde VL ön tan›s› alm›ﬂ 59 olgudan
al›nan serum örneklerinde kuru-dondurulmuﬂ tüm promastigot antijenine dayanan h›zl› aglütinasyon tarama
testi (FAST) ve Direkt aglütinasyon testi (DAT), IFAT ve çözünebilir antijen içeren ELISA yöntemlerinin
etkinlikleri direkt parazitolojik tan› yöntemleri ile karﬂ›laﬂt›r›lm›ﬂt›r.
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Bulgular: Elli dokuz örne¤in 24’ünde parazitolojik olarak VL tan›s› konulmuﬂ ve 35 örnek parazitolojik
incelemede negatif olarak de¤erlendirilmiﬂtir. DAT ve IFAT parazitolojik olarak tan›mlanm›ﬂ tüm örneklerde
pozitif olarak bulunmuﬂtur. FAST ve ELISA ise 23 (% 95.8) örnekte pozitif sonuç vermiﬂtir. Parazitolojik
teknikler ile negative olarak de¤erlendirilen 35 örne¤in dördü DAT, beﬂi FAST ve IFA ve alt›s› ELISA yöntemiyle
pozitif olarak bulunmuﬂtur. ‹statistiksel olarak testler aras›ndaki yüksek derecede uyumluluk (uyumluluk: %
90-96.6; κ de¤eri: 0.82-0.93) saptanm›ﬂt›r.
Sonuç: Bu çal›ﬂma FAST’›n h›zl› ve maliyet etkin bir tarama testi oldu¤unu göstermiﬂtir. Tan› testlerinden DAT,
‹FAT ve ELISA yeterli duyarl›l›¤a sahip oldu¤u ancak kolay uygulanabilirlik ve maliyet aç›ndan DA testinin bizim
bölgemizde VL serolojik tan›s›n› için en uygun test olarak de¤erlendirilmiﬂtir.
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Introduction
Leishmaniasis is infection with a species of flagellate
protozoa belonging to the genus Leishmania that results
in a group of globally widespread parasitic diseases. The
disease is transmitted to humans by the bite of the
infected female sand fly of the genus Phlebotomus (Old
World) or Lutzomyia (New World) (1). The disease
predominantly manifests either in a cutaneous form,
which causes skin ulcers on the exposed parts of the
body, or in a visceral form that is characterized by
prolonged fever, splenomegaly, hepatomegaly,
substantial weight loss, progressive anemia, and/or
pancytopenia (1-3).
Visceral leishmaniasis (VL) is an endemic disease in the
Aegean and Mediterranean basin, including Turkey,
among humans and dogs. VL in this region is caused by
Leishmania infantum and presents itself as the
Mediterranean type of kala azar, which mainly affects
children. Dogs are considered the main reservoir of the
parasite and are primarily responsible for the persistence
of VL in most urban areas (4).
In Turkey, epidemiology of leishmaniasis has not been
extensively investigated and little detailed information is
known about the distribution and prevalence of the
disease, particularly VL. VL is mainly observed as endemic
or sporadic in some areas of western and southern
Turkey along the Aegean and Mediterranean coasts. In
other parts of the country, the disease occurs sporadically
(5). Recent studies have identified an emerging focus of
human and canine disease near major population centers
in the Central Anatolia region (6). Human VL type in
Turkey is consistent with Mediterranean type of VL with
a chronically debilitating disease that is predominantly
seen in children younger than 11 years (7-9).
Since human VL is the most severe clinical
manifestation of the disease that, if left untreated, has a
mortality rate of almost 100%, accurate and rapid
diagnosis is crucial. Clinical diagnosis of VL is supported
by laboratory diagnosis mainly based on demonstration of
parasites in tissue aspirates or cultures of biopsy
specimens or serology (1-3,10).
In Turkey, diagnosis of VL generally relies on
microscopic examination, mostly based on bone marrow
aspirate, and culture of clinical samples in Novy, Nicolle,
and MacNeal (NNN) medium. In addition, specific
serological tests such as indirect immunofluorescent
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antibody test (IFAT), enzyme-linked immunosorbent
assay (ELISA) and rK39 antigen based tests (ELISA and
dipstick) have been applied in the diagnosis of VL in both
human and canine VL with satisfactory results in some
centers (6,11-13). However, the application of IFAT and
ELISA, which need an equipped laboratory with qualified
technicians, is not feasible in remote VL endemic areas
that lack sufficient infrastructure. The direct
agglutination test (DAT), based on freeze-dried L.
donovani promastigote antigen, may provide an
alternative sero-diagnostic test, as it requires little
equipment, no electricity or cold storage of the reagents
and can be easily performed after appropriate training
under harsh field conditions (14,15). However, there is
only one sero-epidemiological study carried out in Turkey
using DAT available in the literature (11). Therefore, the
present study aimed at the evaluation of several serodiagnostic tests, including the agglutination tests, DAT
and fast agglutination screening test (FAST), in
comparison to direct parasitological examination for the
diagnosis of human VL in central Turkey.

Materials and Methods
Patients and Samples
A total of 59 bone marrow aspirations, peripheral
blood smears and serum samples were obtained from
patients (n=59; 42 males, 17 females) who were those
referred to a tertiary care center on the basis of clinical
suspicion of VL with signs of prolonged fever,
splenomegaly
and/or
hepatomegaly
and
anemia/pancytopenia. Pancytopenia was defined as
hemoglobin level <11 g/dl, white blood cell count <4 x
9
9
10 /L, and a platelet count <100 x 10 /L. A questionnaire
with clinical and epidemiological data was completed for
each patient at enrollment.
Diagnostic Procedures
All diagnostic procedures were carried out at Refik
Saydam National Hygiene Center (RSNHC), Department
of Communicable Diseases Research, in Ankara, Turkey.
The following methods were employed:
Parasitology
Standard parasitological examination was performed
by microscopic observation of Giemsa-stained smears and
followed by culture on NNN media. Cultures were
incubated at 24°C and sub-cultured weekly for 4 weeks.
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Serology – Agglutination Tests
The presence of anti-Leishmania antibodies in the
serum samples was determined by FAST, DAT, IFAT and
ELISA as described below.
DAT and FAST, based on freeze-dried antigen
prepared from L. donovani 1S promastigotes, were
provided from Royal Tropical Institute, Amsterdam, the
Netherlands. FAST was performed as described by
Schoone et al. (16). In brief, 20 mL 1:100 diluted serum
in physiological saline (NaCl 0.85%), containing 0.78%
b-mercaptoethanol, was mixed with equal volume antigen
in microtiter plates with V-shaped wells (Greiner,
Germany). The plate was carefully shaken and covered
with a lid. After 3 h incubation at ambient temperature,
the agglutination results were considered as negative
(compact blue dot) or positive (large diffuse blue mat).
Appropriate positive and negative controls were always
included on each plate. DAT was performed as described
previously (17). Briefly, two-fold serial dilutions of sera,
ranging from 1:100 to 1:51200, were prepared in saline
and 0.78% b-mercaptoethanol in V-shaped microtiter
plates. DAT antigen solution (50 µL) was added to each
well containing 50 µL diluted serum and the plate was
covered with a lid. The negative control wells contained
physiologic saline and antigen only. The results were read
after 18 h of incubation at ambient temperature. The
agglutination reaction was visually assessed against a
white background. The end point titer was determined in
reference to a clear sharp-edged blue spot (compact blue
dot) observed in the control wells. Positive and negative
controls were run for each test. Samples with a titer
1:1,600 were considered positive.
Serology – IFAT/ELISA
IFAT was carried out according to the procedure of De
Korte et al. (18) using cultured promastigotes of a local
L. infantum (MON-1) strain as antigen. Briefly,
promastigotes were cultivated in RPMI-1640 containing
10% FCS and subsequently washed by centrifugation and
resuspended at a concentration of 2x106 parasites/ml.
The prepared antigen suspension was dispensed onto
multi-spot IFAT slides. Slides were air-dried and stored at
-20 oC until use. Two-fold serial dilutions of serum in PBS
from 1:16 to 1:256 were transferred onto the antigencoated slides and incubated in a moist chamber for 30
min at 37 °C. After two washes in PBS, slides were
stained with FITC labelled anti-human immunoglobulin G
conjugate (Sigma F-4512, Germany) and incubated for
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30 min at 37 °C. After removal of unbound conjugate by
two washes, the air-dried slides were examined under a
fluorescence microscope. Serum dilutions producing
fluorescence on at least two-thirds of the promastigotes
per view were considered to be positive. An antibody titer
of IgG ≥1:128 was considered as an indication of
Leishmania infection.
Finally, the presence of antibodies against L. infantum
was also determined by a commercially available
Leishmania IgM+IgG ELISA (Vircell SL Granada, Spain)
according to the manufacturer’s instructions.
Statistical Analysis
The data were processed with SPSS for Windows
version 10.0.5 (SPSS, Inc., Chicago, IL). Statistical
analysis of test results was done in terms of sensitivity,
the degree of agreement between tests and Kappa (κ)
values.
Sensitivity was estimated by the classic validation
method. Parasitology was considered as the reference
test in the 2 x 2 contingency table: a patient with a
positive bone marrow aspirate was considered a VL case.
The degree of agreement between FAST, DAT, IFAT
and ELISA was determined by calculating Kappa (κ)
values with 95% confidence intervals using Epi-info
version 6. Kappa values express the agreement beyond
change, and a κ value of 0.21–0.60 represents a fair to
moderate agreement, 0.60–0.80 a substantial agreement
and >0.80 almost perfect agreement beyond change
(19). The calculation of the degree of agreement between
the tests and the κ values for FAST-DAT, DAT-IFAT, DATELISA and IFAT-ELISA were based on the results obtained
with the confirmed and suspected VL serum samples.

Results
Parasitology and Patient Characteristics
Parasitological diagnostic procedures revealed the
presence of Leishmania amastigotes in smears and/or
promastigotes in culture samples in 24 patients (40.7%).
The remaining 35 (59.3%) suspected VL cases had a
negative parasitological work-up.
The median age of the 24 confirmed VL patients was
6.75 years (range: 6 months to 19 years), with 22
(91.7%) confirmed patients under 14 years. The
male:female ratio was 1.67:1. The age distribution of
confirmed VL cases is shown in Figure 1.
15
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Number of cases

8
7

Serology

7
6

6

The results of serological testing of the suspected and
parasitologically confirmed VL patients are presented in
Table 1. Both DAT (agglutination titer ≥1:1600) as well
as IFAT (positive fluorescence titer of ≥ 1:128) scored
100% of the parasitologically confirmed VL patients as
positive. Twenty-three (95.8%) out of 24 confirmed VL
cases were found positive by FAST and ELISA.

6
5
4
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Anti-L. infantum antibody titers determined by DAT
and IFAT are presented in Tables 2 and 3, respectively.
Four out of 35 cases with a parasitologically negative
bone marrow had a positive DAT result, with antibody
titers ranging from 1:3200 to 1:51200. One suspected
patient had a DAT titer below the cut-off value of the
test. The IFAT was positive in five suspected, but
parasitologically not confirmed, VL cases. Three IFATpositive suspected patients only presented a low IFAT
titer (1:64). Furthermore, it was observed that parasitenegative cases were found positive by means of FAST and
ELISA in 5 and 6 cases, respectively.

Figure 1. Age distribution of confirmed visceral leishmaniasis patients
(n = 24) in the present study.

The most common clinical signs for the suspicion of
VL were fever (87.5% of cases), splenomegaly (83.3%),
pallor (75%) and anorexia (35%). The median duration
of symptoms at first admission was eight weeks (range
1.5-52 weeks). Mean ± SD spleen and liver sizes were
6.0 ± 3.1 and 5.0 ± 4.0 cm below the costal margins,
respectively. Anemia was present in 22 (91.6%) of the
24 parasitologically confirmed cases, leukopenia in 16
(75%), and thrombocytopenia in 13 (54.2%) VL patients.
Pancytopenia was present in 10 (41.7%) of the 24
patients.

Statistical Analysis
Calculation of the sensitivity of the assays revealed
that the DAT and IFAT had a sensitivity of 100%,
whereas FAST and ELISA both had a sensitivity of 95.8%.

Table 1. Results of serologic tests in VL patients.
Patient group

FAST (%)

DAT (%)

IFA (%)

ELISA (%)

Parasitology positive (n=24)

23 (95.8)

24 (100)

24 (100)

23 (95.8)

Parasitology negative (n=35)

5 (14.3)

4 (11.4)

5 (14.3)

6 (17.1)

Table 2. DAT results for anti-Leishmania antibodies in suspected and confirmed VL patients.
Serial dilution series (Reciprocal)

16

Patient group

800

1600

3200

Confirmed VL

(-)

(-)

(-)

(-)

(-)

Suspected VL

1

-

1

1

(-)

51200

102400

≥102400

Total (n)

5

4

2

13

24

1

1

(-)

(-)

4

6400 12800 25600
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Table 3. Anti-Leishmania antibody titers determined by IFAT.
IFA Titers
Patient group

1:64

1:128

1:256

1:512

1:1024

1:2048

Total (n)

Confirmed VL

(-)

3

4

9

5

3

24

Suspected VL

3

1

1

(-)

-

-

5

The agreement between the two agglutination tests
was 96.6%, with a calculated agreement beyond change
(κ value) of 0.93 (See Table 4). The agreements (and κ
values) between DAT-IFAT, DAT-ELISA, FAST-IFAT,

FAST-ELISA and IFAT-ELISA were 94.9% (κ value:
0.90), 94.9% (0.90), 91.5% (0.83), 96.5% (0.93) and
90.0% (0.80), respectively (see Table 4).

Table 4. Comparison between DAT, FAST, IFAT and ELISA using serum samples from confirmed and
suspected VL patients.
A. Comparison between DAT and FAST

FAST (+)

FAST (-)

Total

DAT (+)

27

1

28

DAT (-)

1

30

31

Total

28

31

59

B. Comparison between DAT and IFAT

IFA (+)

IFA (-)

Total

DAT (+)

27

1

28

DAT (-)

2

29

31

Total

29

30

59

ELISA (+)

ELISA (-)

Total

27

1

28

DAT (-)

2

29

31

Total

29

30

59

IFA (+)

IFA (-)

Total

C. Comparison between DAT and ELISA
DAT (+)

D. Comparison between FAST and IFAT
FAST (+)

26

2

28

FAST (-)

3

28

31

Total

29

30

59
Total

E. Comparison between FAST and ELISA

ELISA (+)

ELISA (-)

FAST (+)

27

2

29

FAST (-)

1

29

30

Total

28

31

59

F. Comparison between IFA and ELISA

ELISA (+)

ELISA (-)

Total

IFA (+)

26

3

29

IFA (-)

3

27

30

Total

29

30

59
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Discussion
Unequivocal diagnosis of VL requires demonstration
of parasites by Giemsa-stained smears or cultures of
biopsy specimens from bone marrow, liver, enlarged
lymph nodes, or spleen obtained by invasive
procedures. Although demonstration of even a single
amastigote upon microscopic examination of tissue
smears or promastigotes in cultures is considered to be
the gold standard, the sensitivities of these procedures,
except in the case of splenic aspirate, are as low as 5060%. Moreover, the procedures for obtaining tissue
specimens have their own drawbacks, such as
hemorrhage (1-3,10). In addition, identification of
amastigotes requires considerable expertise and training
and is subject to the ability of the observer.
Parasitological techniques are also cumbersome, timeconsuming and require expertise and costly equipment,
severely restricting their use in routine clinical practice
(1,10,14). These mentioned limitations of the direct
diagnostic methods make serology the most useful
diagnostic tool for laboratory diagnosis of VL (2,
3,10,14,20).
The comparison of the performances of agglutination
tests (DAT and FAST) with IFAT and ELISA on serum
samples of confirmed VL cases and suspects from Central
Anatolia is reported. In the present study, the diagnosis
of VL was confirmed with a positive parasitological
procedure in 24 (40.7%) out of 59 VL suspects.
Serology based on the agglutination principle showed
a sensitivity of 100% for DAT and 95.8% for FAST. Our
findings corroborate well with observations from several
other research groups, indicating high sensitivities
(>92% - 100%) for these tests (15,20-26).
In our study, both IFAT and ELISA also showed good
sensitivity values. These two tests are based on sonicated
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L. infantum antigen. The sensitivity of our ELISA assay is
equivalent to that previously reported by several other
research groups (27-29), who reported ELISA
sensitivities varying between 97 to 100%. The sensitivity
of IFAT in the present study is in agreement with the
literature (24,30-32).
All serological tests employed found four to six
additional patients as positive that were parasitologically
negative. These patients were clinically VL suspected and
had signs of the disease. The positive DAT, FAST, IFAT
and ELISA may indicate a low parasitemia in these
patients, which could not be detected by parasitological
examination of their bone marrow aspirates. Perhaps
more sensitive molecular methods, like polymerase chain
reaction (PCR) and nucleic acid sequence based
amplification (NASBA) are capable of detecting these low
numbers of parasites (10,33).
Although the study population was rather small and
the patients were recruited from an emerging focus in
central Turkey, the serological results obtained indicate a
high degree of agreement (agreement: 90-96.6%; κ
value: 0.82-0.93) between the employed tests.
Sophisticated serological tests such as IFAT and ELISA
have not been extensively applied in the sero-diagnosis of
VL in leishmaniasis endemic areas like Turkey, since both
techniques require an equipped laboratory with qualified
technicians. DAT and FAST are highly specific and
sensitive tests as well as simpler and cheaper. They may
provide a good alternative for the invasive and labor
intensive methods that are required to perform a
parasitological diagnosis, in particular in resource-poor
environments. Based on our present experiences, and its
slightly higher sensitivity, the DAT will be our method of
choice for implementation of a serological test for the
diagnosis of VL in our laboratory.
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